Biomarkers of acute myocardial infarction in the elderly: troponin and beyond
Martin G Rains,1 Charles A Laney,1 Alison L Bailey,1 Charles L Campbell1,2 1Gill Heart Institute, Division of Cardiovascular Medicine, University of Kentucky, Lexington, KY, USA; 2Lexington Veterans Administration Hospital, Lexington, KY, USA Abstract: In the broadest context, biological markers, o...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/cf6dea228e9847e2ae86d908cca78112 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Martin G Rains,1 Charles A Laney,1 Alison L Bailey,1 Charles L Campbell1,2 1Gill Heart Institute, Division of Cardiovascular Medicine, University of Kentucky, Lexington, KY, USA; 2Lexington Veterans Administration Hospital, Lexington, KY, USA Abstract: In the broadest context, biological markers, or biomarkers, are molecules that characterize a biological system or process. In the setting of cardiovascular disease, a number of biomarkers have become an integral part of diagnostic and risk stratification strategies. In this review, we will discuss classic and emerging biomarkers of cardiovascular disease and the role of these biomarkers in the diagnosis and prognosis of elderly patients presenting with acute myocardial infarction. Keywords: cardiovascular disease, biological markers, diagnosis, prognosis |
|---|